Health Care & Life Sciences » Pharmaceuticals | HPGC Renmintongtai Pharmaceutical Corp.

HPGC Renmintongtai Pharmaceutical Corp. A | Income Statement

Fiscal year is January-December. All values CNY Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
3,150
1,718
8,888
8,982
7,981
7,032
Cost of Goods Sold (COGS) incl. D&A
1,911
874
7,951
8,122
7,101
6,173
Gross Income
1,239
845
936
860
880
859
SG&A Expense
1,184
714
681
552
527
491
EBIT
41
111
244
308
353
368
Unusual Expense
14
41
10
4
4
6
Non Operating Income/Expense
12
32
4
1
9
1
Interest Expense
17
18
18
7
22
27
Pretax Income
65
52
229
303
340
346
Income Tax
64
26
97
78
86
88
Equity in Affiliates
9
-
-
-
-
-
Consolidated Net Income
8
26
133
225
254
258
Net Income
6
40
139
225
254
258
Net Income After Extraordinaries
6
40
139
225
254
258
Net Income Available to Common
6
40
139
225
254
258
EPS (Basic)
0.01
0.07
0.24
0.39
0.44
0.44
Basic Shares Outstanding
580
580
580
580
580
580
EPS (Diluted)
0.01
0.07
0.24
0.39
0.44
0.44
Diluted Shares Outstanding
580
580
580
580
580
580
EBITDA
136
203
295
338
387
400
Other Operating Expense
-
13
19
12
1
-
Non-Operating Interest Income
5
5
5
5
4
5
Minority Interest Expense
-
14
14
6
-
-

About HPGC Renmintongtai Pharmaceutical

View Profile
Address
418 Hayao Road
Harbin Heilongjiang 150071
China
Employees -
Website http://www.hyrmtt.com.cn
Updated 07/08/2019
HPGC Renmintongtai Pharmaceutical Corp. engages in the wholesale and retail of pharmaceutical products. It operates through the following business segments: Drug retail, Commercial wholesale, Logistics, E-commerce, Specialist hospital, and Chinese medicine. The Drug retail segment includes chain drugstores and network distribution of pharmaceutical products.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.